But as an investor focused on extending healthy human life, I’ve found the opposite to be true. Awards may be encouraging and occasionally useful for visibility, but they are weak indicators of validation and poor predictors of long-term success. In the longevity and healthspan industry, where timelines are long and claims are easy to overstate, venture capital ultimately follows alignment and evidence, not applause received at glitzy industry events.
Lex: FT's flagship investment column
。体育直播对此有专业解读
Copyright © 1997-2026 by www.people.com.cn all rights reserved。搜狗输入法下载是该领域的重要参考
Though he declined to reveal exact numbers, Baronchelli says the platform has averaged 50% growth year-on-year—a figure that he hopes to maintain.
Opinions expressed by Entrepreneur contributors are their own.